These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7782114)

  • 1. Prevention of Pneumocystis carinii pneumonia and of cerebral toxoplasmosis by roxithromycin in HIV-infected patients.
    Durant J; Hazime F; Carles M; Pechere JC; Dellamonica P
    Infection; 1995; 23 Suppl 1():S33-8. PubMed ID: 7782114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
    Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
    N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Tocchetti A; Tambini R; Allegro A; Longoni E; Rinaldi E
    AIDS; 1994 Feb; 8(2):272-4. PubMed ID: 8043236
    [No Abstract]   [Full Text] [Related]  

  • 4. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses.
    May T; Beuscart C; Reynes J; Marchou B; Leclercq P; Borsa Lebas F; Saba J; Micoud M; Mouton Y; Canton P
    J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):457-62. PubMed ID: 8158539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
    Mallolas J; Zamora L; Gatell JM; Miró JM; Vernet E; Valls ME; Soriano E; SanMiguel JG
    AIDS; 1993 Jan; 7(1):59-64. PubMed ID: 8442918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Torres RA; Barr M; Thorn M; Gregory G; Kiely S; Chanin E; Carlo C; Martin M; Thornton J
    Am J Med; 1993 Dec; 95(6):573-83. PubMed ID: 8018144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
    Opravil M; Hirschel B; Lazzarin A; Heald A; Pechère M; Rüttimann S; Iten A; von Overbeck J; Oertle D; Praz G
    Clin Infect Dis; 1995 Mar; 20(3):531-41. PubMed ID: 7756472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine].
    Koch A; Kothe H; Braun J; Kämmerer R; Friedrich HJ; Dalhoff K
    Pneumologie; 1998 Nov; 52(11):614-21. PubMed ID: 9885511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group.
    Rizzardi GP; Lazzarin A; Musicco M; Frigerio D; Maillard M; Lucchini M; Moroni M
    J Infect; 1996 Mar; 32(2):123-31. PubMed ID: 8708369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose aerosol pentamidine for secondary Pneumocystis carinii pneumonia prophylaxis in AIDS patients.
    Flamholc L; Haidl S; Westin E; Borgdalen L; Prellner T
    Infection; 1992; 20(6):309-12. PubMed ID: 1293048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of Pneumocystis carinii pneumonia associated with HIV infection using pentamidine aerosols. Retrospective study of 465 cases].
    Guinet F; Pialoux G; Trotot P; Chauvelle MT; Feuillie V; Sansonetti P; Dupont B
    Presse Med; 1994 Dec; 23(38):1747-52. PubMed ID: 7831262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary and secondary prevention of Pneumocystis carinii pneumonia with pentamidine aerosol. Effectiveness, side effects and incidence of extrapulmonary Pneumocystis carinii manifestations].
    Stoehr A; Plettenberg A; Albrecht H; Stellbrink HJ; Meigel W; Begemann F
    Med Klin (Munich); 1994 Mar; 89(3):132-5. PubMed ID: 8196573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of common HIV-associated opportunistic complications.
    Carmichael C
    Prim Care; 1997 Sep; 24(3):561-74. PubMed ID: 9271692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of Pneumocystis carinii pneumonia in HIV patients receiving 300 mg pentamidine aerosol every 2 weeks.
    Kronawitter U; Bogner JR; Goebel FD
    Clin Investig; 1992 Dec; 70(12):1089-91. PubMed ID: 1467635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus.
    Opravil M; Pechère M; Lazzarin A; Heald A; Rüttimann S; Iten A; Furrer H; Oertle D; Praz G; Vuitton DA
    Clin Infect Dis; 1995 Feb; 20(2):244-9. PubMed ID: 7742423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC; Rimland D
    Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular pentamidine for the prevention of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
    Cheung TW; Matta R; Neibart E; Hammer G; Chusid E; Sacks HS; Szabo S; Rose D
    Clin Infect Dis; 1993 Jan; 16(1):22-5. PubMed ID: 8448314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study.
    Heald A; Flepp M; Chave JP; Malinverni R; Rüttimann S; Gabriel V; Renold C; Sugar A; Hirschel B
    Ann Intern Med; 1991 Nov; 115(10):760-3. PubMed ID: 1929023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. A randomized, placebo-controlled study.
    Montaner JS; Lawson LM; Gervais A; Hyland RH; Chan CK; Falutz JM; Renzi PM; MacFadden D; Rachlis AR; Fong IW
    Ann Intern Med; 1991 Jun; 114(11):948-53. PubMed ID: 2024862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.